Ultimately, based on the full GLP-1 RA psychiatric AE reporting profile, we filtered eight positive signals for psychiatric AEs with ROR05 greater than 1 and defined them as GLP-1 RA-related psychiatric AEs, namely, nervousness ( n = 941
While tirzepatide is not approved to treat Hashimoto's disease itself and does not modify the autoimmune process, it may benefit patients who meet criteria for obesity treatment
For Saxenda (liraglutide 3 mg), treatment should be discontinued if a patient has not lost at least 5% of their initial body weight after 12 weeks on the 3 mg daily dose
Prescribers must confirm local jurisdictional scope before initiating therapy
Second, GLP-1s improve inflammation, microvascular health, and insulin signalling in the body in ways that support brain networks indirectly